IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 114 filers reported holding IMMUNOVANT INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,702,101 | +103.6% | 96,434 | +0.6% | 0.03% | +93.8% |
| Q2 2023 | $1,818,388 | +36.6% | 95,856 | +11.7% | 0.02% | +33.3% |
| Q1 2023 | $1,330,960 | -14.4% | 85,813 | -2.0% | 0.01% | -14.3% |
| Q4 2022 | $1,554,332 | +337.8% | 87,568 | +37.5% | 0.01% | +366.7% |
| Q3 2022 | $355,000 | +31.5% | 63,672 | -7.9% | 0.00% | 0.0% |
| Q2 2022 | $270,000 | -59.0% | 69,110 | -42.2% | 0.00% | -57.1% |
| Q1 2022 | $659,000 | -41.9% | 119,625 | -10.1% | 0.01% | -46.2% |
| Q4 2021 | $1,134,000 | -7.4% | 133,092 | -5.6% | 0.01% | +8.3% |
| Q3 2021 | $1,225,000 | -10.2% | 140,952 | +9.2% | 0.01% | 0.0% |
| Q2 2021 | $1,364,000 | -52.0% | 129,048 | -27.2% | 0.01% | -57.1% |
| Q1 2021 | $2,843,000 | -60.9% | 177,246 | +12.6% | 0.03% | -65.9% |
| Q4 2020 | $7,270,000 | – | 157,400 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |